KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other financing activities (2016 - 2022)

Historic Other financing activities for Bristol Myers Squibb (BMY) over the last 14 years, with Q4 2022 value amounting to $179.0 million.

  • Bristol Myers Squibb's Other financing activities rose 606666.67% to $179.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $984.0 million, marking a year-over-year increase of 5351.01%. This contributed to the annual value of $27.0 million for FY2023, which is 9725.61% down from last year.
  • Bristol Myers Squibb's Other financing activities amounted to $179.0 million in Q4 2022, which was up 606666.67% from $53.0 million recorded in Q3 2022.
  • In the past 5 years, Bristol Myers Squibb's Other financing activities registered a high of $419.0 million during Q2 2022, and its lowest value of -$58.0 million during Q1 2018.
  • In the last 5 years, Bristol Myers Squibb's Other financing activities had a median value of $35.5 million in 2020 and averaged $103.0 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Other financing activities plummeted by 140000.0% in 2019, and later surged by 1720000.0% in 2020.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Other financing activities stood at $1.0 million in 2018, then plummeted by 1400.0% to -$13.0 million in 2019, then surged by 2230.77% to $277.0 million in 2020, then crashed by 101.08% to -$3.0 million in 2021, then soared by 6066.67% to $179.0 million in 2022.
  • Its Other financing activities was $179.0 million in Q4 2022, compared to $53.0 million in Q3 2022 and $419.0 million in Q2 2022.